arrow
S

Shuofeng Yuan

The University of Hong Kong
H指数:49
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lung epithelial endothelin-1 drives iron dysregulation and skeletal injury after SARS-CoV-2 infection

SARS-CoV-2感染后肺上皮内皮素-1驱动铁代谢紊乱和骨骼损伤

2026-08-010
OAAI
Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants

广谱大环肽抑制剂的鼻内给药可防止SARS-CoV-2 Omicron变体

2026-01-260
OA
Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo

作者更正:一种口服可用的Mpro/TMPRSS2双特异性抑制剂,具有体内强效抗冠状病毒疗效

2025-12-150
OAAI
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1

SARS-CoV-2 JN.1衍生变体 (包括JN.1.7、KP.2、KP.3和KP.3.1.1) 的致病性、病毒学特征和免疫逃避

2025-12-110
OAAI
Structure-guided discovery of a small molecule inhibitor of SARS-CoV-2 main protease with potent in vitro and in vivo antiviral activities
2025-11-010
PRE
iMeta Conference 2025: Creating high-impact international journals

iMeta Conference 2025:创建具有高影响力的国际期刊

iMeta
IF33.2
2025-10-150
OAAI
The microbiome in cancer

肿瘤微生态

iMeta
IF33.2
2025-08-300
OAAI
Broad neuraminidase antibodies confer protection against seasonal and avian influenza viruses

广谱神经氨酸酶抗体对季节性和禽流感病毒具有保护作用

2025-08-020
OAAI
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo

一种口服可用的Mpro/TMPRSS2双特异性抑制剂,具有体内强效抗冠状病毒活性

2025-07-160
OA
Reverse genetics-derived cattle H5N1 virus from Clade 2.3.4.4b shows enhanced systemic infectivity and pathogenicity than an older Clade 1 H5N1 virus in BALB/c mice

反向遗传学衍生的2.3.4.4b分支牛源H5N1病毒在小鼠中表现出比更早的1分支H5N1病毒更强的系统性感染力和致病性。

2025-03-170
OAAI